Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a prominent biopharmaceutical company headquartered in Cambridge, Massachusetts, founded in 2002 The company specializes in the development of innovative therapeutics based on RNA interference technology Alnylam has made significant investments in its research and development initiatives, with an investment scale of approximately $30 million The organization is committed...